BPAF (Bisphenol AF) in the bedroom

At a glance

Regulatory & certification status

Where BPAF (Bisphenol AF) stands across the major regulatory systems and the certifications a bedroom product might carry. Each row links to the governing instrument; where a jurisdiction has no specific measure, that is stated plainly rather than left blank.

What it is

BPAF — bisphenol AF, CAS 1478-61-1 — is a fluorinated analog of bisphenol A. Two trifluoromethyl (-CF₃) groups replace BPA's two methyl groups on the central carbon, which increases thermal and chemical stability considerably. That property is exactly why industry wants it: BPAF is used as a crosslinking reagent and monomer in the production of fluoroelastomers, fluoropolymers, and specialty high-performance coatings — materials that need to hold up under heat and chemical stress in ways ordinary plastics don't.

It is a genuinely small-volume specialty chemical. No REACH full registration dossier existed for it prior to its 2026 SVHC listing, which implies EU production/import volumes below the standard 100-tonnes-per-year registration threshold — several orders of magnitude below BPA, which is produced in the millions of tonnes globally. That distinction matters for how to read everything that follows: BPAF's laboratory hazard profile is concerning, but it is not manufactured or used anywhere near the scale that would put it in daily contact with most households.

How it relates to the bedroom / where you encounter it

Not a foam, textile, or thermal-paper chemical — mostly

Unlike BPA and BPS, BPAF is not a routine ingredient in mattress foam, bedding textiles, or thermal receipt paper. Its applications sit further upstream in specialty industrial chemistry: fluoroelastomer seals and gaskets, fluoropolymer coatings, and as a crosslinking monomer. That means the exposure pathways that matter most for other bisphenols in this Atlas — off-gassing from foam, skin contact with receipts, dust from BPA-free plastics — are largely not BPAF's pathways.

What the exposure data actually shows

A 2012 peer-reviewed study measuring eight bisphenol analogues in indoor dust from the United States and several Asian countries included BPAF among the compounds analyzed, alongside BPA and BPS. Peer-reviewed — Liao et al. 2012, Environ. Sci. Technol. BPA and BPS were the dominant bisphenols detected across nearly all samples; BPAF was included in the analyte panel but was not among the compounds reported at high detection frequency in that study, consistent with its far smaller production volume.

More directly relevant to this Atlas's usual audience: a 2020 Swiss study extracted urine from 109 diapers at daycare centers to biomonitor bisphenol exposure in infants and toddlers, testing for 15 bisphenol compounds including BPAF. Peer-reviewed — Lucarini et al. 2020, Int J Environ Res Public Health Seven of the fifteen bisphenols were detected — BPM, BPC, BPA, BPF, BPS, among others — but BPAF concentrations were below the limit of detection in every sample. The authors note other studies have detected trace BPAF elsewhere (the highest reported level they cite, 0.018 µg/L, comes from a 2013 Chinese cohort), but in this dataset, in this population, it wasn't found.

The honest bedroom-relevance verdict

We are not going to manufacture bedroom relevance that the data doesn't support. BPAF's inclusion in this Atlas is about completing the bisphenol family picture and correcting a common assumption — that "BPA-free" automatically means safer — rather than because we have direct evidence of BPAF accumulating in mattresses, bedding, or bedroom dust at meaningful levels. If your product specifically uses fluoroelastomer components (some mattress zipper hardware, certain waterproof or heat-resistant coatings) BPAF is a plausible trace source; for the vast majority of bedrooms, it is not a primary chemical of concern the way BPA, BPS, or flame retardants are.

What the research says

• Receptor-binding potency is high relative to BPA. In a peer-reviewed radioligand competition assay, BPAF was roughly 20 times more potent than BPA at binding estrogen receptor alpha (ERα IC50 = 53.4 nM vs. BPA's 1,030 nM) and roughly 48 times more potent at ERβ (IC50 = 18.9 nM vs. BPA's 900 nM). In a reporter-gene assay, BPAF acted as a full agonist at ERα (EC50 = 58.7 nM) but as a strong, selective antagonist at ERβ — a distinct pharmacological profile from BPA, which in the same study line was comparatively more active at estrogen-related receptor gamma (ERRγ). Peer-reviewed — Matsushima et al. 2010, Environ. Health Perspect.
• NTP's 2022 rat study found clear evidence of harm at multiple endpoints. In a modified one-generation feeding study (doses of 338, 1,125, and 3,750 ppm in feed), NTP concluded there was "clear evidence of reproductive toxicity" — disrupted estrous cyclicity, decreased implantation sites and live litters at lower doses, and complete failure of the F1 generation to reproduce at the highest dose — and "clear evidence of developmental toxicity," including accelerated vaginal opening (early female puberty) at all doses, delayed balanopreputial separation (late male puberty) at mid and high doses, fetal malformations, and reduced offspring body and organ weights. Regulatory — NTP DART Report 08, 2022
• Direct human exposure data specific to BPAF is sparse and, where measured, often negative. The Swiss pediatric biomonitoring study found no detectable BPAF in 109 samples; the multi-country indoor-dust study included BPAF in its panel without reporting it as a dominant analogue. Peer-reviewed
• Production scale is small. The absence of a full REACH registration dossier prior to 2026 implies EU volumes under roughly 100 tonnes/year — far below BPA's global production, which is measured in the millions of tonnes. Inferred — from REACH registration-threshold logic

What helps / what does NOT help

What helps. If you know a specific product contains fluoroelastomer components (specialty gaskets, waterproof coatings, some technical textiles) and want to minimize contact, treat it the same way you would any bisphenol source: avoid direct, prolonged skin contact where practical, and prefer products that disclose their material composition. Activated carbon is a reasonable general capture strategy for bisphenols as a class, though it has not been independently validated for BPAF specifically. Inferred — from general bisphenol adsorption behavior, not BPAF-specific testing

What does NOT help. Treating "BPA-free" labeling as reassurance without knowing which replacement bisphenol was used. BPAF is one of many possible substitutes (alongside BPS, BPF, BADGE), and a "BPA-free" claim says nothing about which one — if any — is present, or at what hazard level. For BPAF specifically, worrying about routine bedroom exposure without evidence of a specific fluoroelastomer or fluoropolymer source in your home is not a productive use of concern; the data does not support treating it as a background bedroom contaminant the way BPA or BPS are.

Open research questions

• Whether BPAF is detectable in mattress components, bedding hardware, or waterproof coatings specifically marketed for beds and cribs — no published study has tested this directly. Speculation
• Whether the sharp difference between BPAF's laboratory receptor potency and its near-absence in biomonitoring studies reflects genuinely low exposure, analytical detection limits that are too high, or a narrower set of exposure pathways than other bisphenols. Speculation
• Whether the outcome of OEHHA's p,p'-bisphenol class review (data call-in closed December 2025) will result in a Proposition 65 listing for BPAF specifically, and on what timeline. Speculation

Citations

1. National Toxicology Program (2022). NTP Developmental and Reproductive Toxicity Technical Report on the Modified One-Generation Study of Bisphenol AF (CASRN 1478-61-1) Administered in Feed to Sprague Dawley Rats. DART Report 08. DOI 10.22427/NTP-DART-08 Regulatory
2. Matsushima A, Liu X, Okada H, Shimohigashi M, Shimohigashi Y (2010). Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ. Environmental Health Perspectives, 118(9):1267–1272. PMC2944088 Peer-reviewed
3. Liao C, Liu F, Guo Y, Moon H-B, Nakata H, Wu Q, Kannan K (2012). Occurrence of Eight Bisphenol Analogues in Indoor Dust from the United States and Several Asian Countries: Implications for Human Exposure. Environmental Science & Technology, 46(16):9138–9145. DOI 10.1021/es302004w Peer-reviewed
4. Lucarini F, Krasniqi T, Bailat Rosset G, Roth N, Hopf NB, Broillet M-C, Staedler D (2020). Exposure to New Emerging Bisphenols Among Young Children in Switzerland. International Journal of Environmental Research and Public Health, 17(13):4793. DOI 10.3390/ijerph17134793 Peer-reviewed
5. European Chemicals Agency. Candidate List of substances of very high concern for authorisation — Bisphenol AF added 4 February 2026. ECHA Candidate List Regulatory
6. OEHHA (2025). Request for Relevant Information on the Reproductive Toxicity of p,p'-Bisphenol Chemicals (includes Bisphenol AF), 21 October 2025. OEHHA Regulatory
7. Government of Canada. Bisphenol A Structural Analogues and Functional Alternatives — Chemicals Management Plan. Government of Canada · Canada Gazette, 13 Nov 2021 Regulatory
8. HSE (UK REACH). Candidate List of Substances of Very High Concern. HSE Regulatory
9. CertiPUR-US Slabstock Technical Guidelines (2025). CertiPUR-US Industry
10. OEKO-TEX (2025). New regulations press release — Standard 100 bisphenol A limit update. OEKO-TEX Industry

Frequently asked questions

• Is BPAF more dangerous than BPA?

  In receptor-binding assays, yes — BPAF binds the estrogen receptor far more potently than BPA (about 20-fold at ERα and roughly 48-fold at ERβ in one peer-reviewed radioligand study), and NTP's 2022 rat feeding study found clear evidence of reproductive and developmental toxicity. But "more potent in a lab assay" is not the same as "more of a bedroom exposure." BPAF is produced and used in far smaller volumes than BPA, in specialty fluoropolymer and coating applications rather than food-contact plastics or thermal paper, so the exposure side of the equation is genuinely much smaller — even though the hazard side, per unit of exposure, appears larger.

• Will I encounter BPAF in my mattress or bedding?

  Probably not in meaningful amounts, and we say that plainly rather than imply otherwise. BPAF's main uses are fluoroelastomers, fluoropolymer coatings, and specialty adhesives — not mattress foam, standard textiles, or thermal receipt paper. A 2020 Swiss biomonitoring study that measured 15 bisphenols in young children's urine detected seven of them but found BPAF below the detection limit in all 109 samples. That is one dataset, not a guarantee of zero exposure everywhere, but it does not support a strong bedroom-relevance claim.

• Is BPAF regulated yet?

  It moved from largely unregulated to actively reviewed in a short window. The EU added BPAF to its REACH Candidate List of Substances of Very High Concern on 4 February 2026 for reproductive toxicity, and it already carries a harmonised EU hazard classification as a Category 1B reproductive toxicant (H360Fd) that applied from 1 September 2025. In the US, California's OEHHA opened a data call-in on 21 October 2025 to consider listing the entire class of p,p'-bisphenol chemicals — which explicitly includes BPAF — under Proposition 65; that is a proposed step, not a final listing. BPAF itself is not yet on the Prop 65 list.

• Why was BPAF studied by the NTP in the first place?

  NTP selected BPAF for its 2022 modified one-generation study specifically because it is structurally related to BPA, was suspected of endocrine activity, had inadequate existing toxicity data, and — as a fluorinated compound — was flagged for potential environmental persistence. That is a research-prioritization rationale, not a finding; the findings came afterward and were serious: clear evidence of reproductive toxicity (disrupted estrous cycling, failure of the F1 generation to reproduce at the highest dose) and clear evidence of developmental toxicity (accelerated female puberty, delayed male puberty, fetal malformations) in rats.

Related compounds

• BPA — the parent bisphenol; the mass-market compound BPAF was designed to replace
• BPS — the most common BPA replacement; far higher production volume and biomonitoring detection than BPAF
• BPF — another structural BPA replacement with similar endocrine-activity concerns
• BADGE — bisphenol A diglycidyl ether; the epoxy-resin bisphenol derivative found in can linings and coatings

Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress.

Last reviewed 2026-07-07. If you find a factual error, contact us.